Results 21 to 30 of about 122,337 (231)

Upper bound estimate of character sums over Lehmer’s numbers [PDF]

open access: yesJournal of Inequalities and Applications, 2013
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Han, Di, Zhang, Wenpeng
openaire   +2 more sources

Character sums with division polynomials

open access: yes, 2011
We obtain nontrivial estimates of quadratic character sums of division polynomials $\Psi_n(P)$, $n=1,2, ...$, evaluated at a given point $P$ on an elliptic curve over a finite field of $q$ elements.
Igor E. Shparlinski   +5 more
core   +1 more source

Estimates of character sums with exponential function [PDF]

open access: yesActa Arithmetica, 2001
Let \(n \geq 2\) and \(\lambda\) be integers satisfying \((n, \lambda)=1\) and \(\lambda\) belonging to the exponent \(d\) modulo \(n\). Given a primitive Dirichlet character \(\chi\) mod \(n\) the author proves the estimate \[ \left|\sum_{x=1}^X \chi(a \lambda^x +b) \right|< \sqrt{n} \left( \frac{2}{\pi} \log n + \frac{7}{5} \right).
openaire   +1 more source

Why and When Are Evidence‐Based Interventions Adopted in Paediatric Supportive Care? A Qualitative Exploration of the Determinants of Photobiomodulation Implementation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Oral mucositis is a common and debilitating side effect of childhood cancer and stem cell transplant treatments. It affects the quality of life of children and young people (CYP) and places a strain on services. Photobiomodulation is recommended for oral mucositis prevention in international guidance but is poorly implemented in UK ...
Claudia Heggie   +4 more
wiley   +1 more source

Deep Holes in Reed-Solomon Codes Based on Dickson Polynomials

open access: yes, 2016
For an $[n,k]$ Reed-Solomon code $\mathcal{C}$, it can be shown that any received word $r$ lies a distance at most $n-k$ from $\mathcal{C}$, denoted $d(r,\mathcal{C})\leq n-k$. Any word $r$ meeting the equality is called a deep hole. Guruswami and Vardy (
Keti, Matt, Wan, Daqing
core   +1 more source

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges   +12 more
wiley   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Computing Dirichlet character sums to a power-full modulus

open access: yes, 2014
The Postnikov character formula is used to express large portions of a Dirichlet character sum in terms of quadratic exponential sums. The quadratic sums are then computed using an analytic algorithm previously derived by the author.
Hiary, Ghaith A.
core   +1 more source

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy